MeSH term
Frequency | Condition_Probility | Animals | 18 | 0.0 |
Cells, Cultured | 5 | 0.0 |
DNA Primers | 2 | 0.0 |
Humans | 56 | 0.0 |
RNA, Messenger/genetics | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 37 | 0.0 |
Tissue Inhibitor of Metalloproteinase-2/genetics | 3 | 50.0 |
Adult | 11 | 0.0 |
Comparative Study | 8 | 0.0 |
DNA, Complementary/isolation & purification | 2 | 1.0 |
Female | 21 | 0.0 |
Male | 19 | 0.0 |
Middle Aged | 15 | 0.0 |
Polymerase Chain Reaction | 6 | 0.0 |
DNA Primers/chemistry | 4 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 3 | 0.0 |
Mice | 11 | 0.0 |
Mice, Nude | 7 | 0.0 |
Neoplasm Invasiveness | 6 | 0.0 |
RNA, Messenger/analysis | 7 | 0.0 |
Tissue Inhibitor of Metalloproteinase-1/*genetics | 2 | 12.0 |
Tissue Inhibitor of Metalloproteinase-2/*genetics | 3 | 42.0 |
Tumor Cells, Cultured | 12 | 0.0 |
Enzyme Activation | 4 | 0.0 |
Enzyme Precursors/metabolism | 3 | 2.0 |
Models, Biological | 3 | 0.0 |
Molecular Sequence Data | 9 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Gelatinase A/*biosynthesis | 2 | 22.0 |
Immunohistochemistry | 10 | 0.0 |
Prognosis | 5 | 0.0 |
Survival Analysis | 2 | 0.0 |
Aged | 10 | 0.0 |
Enzyme Activation/drug effects | 3 | 0.0 |
Gelatinase A/genetics/metabolism | 2 | 22.0 |
Fetal Membranes, Premature Rupture/*metabolism | 2 | 50.0 |
Gelatinase A/metabolism | 2 | 3.0 |
Gelatinase B/metabolism | 2 | 3.0 |
Pregnancy | 4 | 0.0 |
Tissue Inhibitor of Metalloproteinase-2/metabolism | 4 | 18.0 |
Matrix Metalloproteinases/*analysis | 2 | 28.0 |
Tissue Inhibitor of Metalloproteinases/*analysis | 2 | 100.0 |
Dose-Response Relationship, Drug | 4 | 0.0 |
Enzyme Inhibitors/pharmacology | 2 | 0.0 |
Gelatinase A/*metabolism | 5 | 15.0 |
Metalloendopeptidases/biosynthesis/genetics | 3 | 42.0 |
Protein-Tyrosine Kinase/metabolism | 2 | 0.0 |
RNA, Messenger/biosynthesis/genetics | 2 | 0.0 |
Tissue Inhibitor of Metalloproteinase-2/biosynthesis/genetics | 3 | 37.0 |
Tyrosine/metabolism | 2 | 0.0 |
Adolescent | 3 | 0.0 |
Aged, 80 and over | 4 | 0.0 |
Child | 2 | 0.0 |
Child, Preschool | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 8 | 0.0 |
Tissue Inhibitor of Metalloproteinase-2/genetics/metabolism | 2 | 18.0 |
Antibodies, Monoclonal | 2 | 0.0 |
Neoplasm Staging | 2 | 0.0 |
Survival Rate | 2 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
In Vitro | 3 | 0.0 |
Metalloendopeptidases/metabolism | 2 | 3.0 |
Time Factors | 2 | 0.0 |
Base Sequence | 8 | 0.0 |
Breast Neoplasms/*genetics | 2 | 0.0 |
Gelatinase B/*metabolism | 2 | 6.0 |
Gelatinase A | 8 | 11.0 |
Interstitial Collagenase | 2 | 4.0 |
Blotting, Northern | 3 | 0.0 |
Metalloendopeptidases/*metabolism | 3 | 3.0 |
Rats | 4 | 0.0 |
Reference Values | 2 | 0.0 |
Transforming Growth Factor beta/*metabolism/pharmacology | 2 | 8.0 |
Cell Membrane/metabolism | 2 | 0.0 |
In Situ Hybridization, Fluorescence | 2 | 0.0 |
Metalloendopeptidases/antagonists & inhibitors | 2 | 9.0 |
Restriction Mapping | 2 | 0.0 |
Tissue Inhibitor of Metalloproteinases/*genetics | 2 | 50.0 |
In Situ Hybridization | 3 | 0.0 |
Tissue Inhibitor of Metalloproteinase-2 | 9 | 32.0 |
Tissue Inhibitor of Metalloproteinases | 6 | 9.0 |
Biopsy | 3 | 0.0 |
Disease Progression | 2 | 0.0 |
Immunoenzyme Techniques | 4 | 0.0 |
Chromosome Mapping | 3 | 0.0 |
Polymorphism, Restriction Fragment Length | 2 | 0.0 |
Neoplasm Metastasis | 3 | 0.0 |
*Protein Biosynthesis | 4 | 0.0 |
Protease Inhibitors/*metabolism | 2 | 11.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Tissue Inhibitor of Metalloproteinase-2/*biosynthesis | 2 | 100.0 |
*Chromosomes, Human, Pair 17 | 3 | 0.0 |
Hybrid Cells | 2 | 0.0 |
Culture Media, Conditioned/pharmacology | 2 | 1.0 |
Gelatinase B | 3 | 3.0 |
Gelatinases/metabolism | 2 | 6.0 |
Immunoblotting | 2 | 0.0 |
Matrix Metalloproteinases/*metabolism | 2 | 5.0 |
Cell Division | 3 | 0.0 |
Glycoproteins/*biosynthesis/genetics | 2 | 13.0 |
Neoplasm Transplantation | 2 | 0.0 |
Proteins/genetics | 2 | 0.0 |
Blotting, Western | 2 | 0.0 |
Extracellular Matrix/*enzymology | 2 | 15.0 |
English Abstract | 3 | 0.0 |
Mutation | 2 | 0.0 |
Cell Division/drug effects | 2 | 0.0 |
